4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001062993-23-020924
Options or other derivatives
- Chief Operations Officer acquired 7,269.97 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kurtoglu Metin Chief Operations Officer | 2023-11-13 | Grant or award · Stock Option (Right to Buy) | +6,414.68 | 6,414.68 | D | ||
| Kurtoglu Metin Chief Operations Officer | 2023-11-13 | Grant or award · Stock Option (Right to Buy) | +427.65 | 427.65 | D | ||
| Kurtoglu Metin Chief Operations Officer | 2023-11-13 | Grant or award · Stock Option (Right to Buy) | +427.65 | 427.65 | D | ||
Loading xslF345X05/form4.xml…